Background: Selenium has been shown to protect against liver necrosis. Selenium deficiency has been involved in the pathogenesis of chronic hepatitis B and C related hepatocellular damage.Serum selenium concentration in cirrhotics was found tobe low, supportive selenium administration may be beneficial for them.Reduced selenium levels result in accumulation of lipid peroxides which accelerate the growth of hepatocellular carcinoma (HCC). Aim: To study serum selenium level in patients with chronic liver diseases and its relation with severity of theliver diseases. Patients and Methods: This case-control study was conducted on 100 subjects. The cases were 80 adult patients including chronic hepatitis C and B, liver cirrhosis and HCC.The study also included 20 healthy age and sex-matched subjects served as a control group. Clinical, laboratory and radiological data and blood samples were collected from all participants. Serum selenium concentration was measured and statistical analysis was done. Results: Selenium concentration was significantly lower in patients compared to healthy controls.Selenium levelwas found low in Chronic HBV, chronic HCV patients and lower incirrhotic group and the lowest in HCC group. Patients with advanced liver cirrhosis (Child B, C) had significantly lower selenium level compared to those with Child A. Conclusion: Selenium was lower in patients with chronic liver disease and its leveldecreases with the progression of liver disease. Patients with HCC had the lowest Selenium concentration that might correlate with the pathophysiology of HCC. Chronic hepatitis C and B, liver cirrhosis and HCC were independent predictors forSelenium deficiency.
Introduction
Selenium (Se) is an essential trace element for humans. It is the essential component of several major metabolic pathways, being the constituent of human selenoproteins (Burk, 2002) . The most important and known action is its antioxidant effect because it forms selenocysteine, part of the active center of the glutathione peroxidase (GSH-Px) enzyme (Navarro-Alarcon et al., 2000). Selenium deficiency induces some pathological conditions, such as cancer, coronary heart disease, and liver necrosis Selenium has been shown to protect against dietary liver necrosis, its selenoenzyme glutathione peroxidase protects the bio membranes from oxidative destruction, and the decreased level of this enzyme increases the tendency of cellular damage (Leccia et al., 1995).
Serum selenium concentration in cirrhotics was found tobe low, supportive selenium administration may be beneficial (Burk, 2002).Selenium deficiency has been involved in the pathogenesis of chronic hepatitis B and C through progressive immune dysfunction effects, resulting impairment of the activities of The deficiency of selenium is common in patients with hepatitis due to poor appetite during infection, decrease in intake and absorption, decreased bioavailability, and increased lossesbecause of mal absorption(Raufet al., 2012). Reduced selenium levels result in accumulation of lipid peroxides. This leads to enhanced AP-1 activation and consequently to elevated expression of VEGF and IL-8, which accelerate the growth of HCC (Jiang C et al., 2000) .
Aim of the work
To study the level of serum selenium in patients with chronic liver disease and its relation with severity of chronic liver diseases.
Patients And Methods
In order to study the level of serum selenium in patients with chronic liver diseases compared to healthy controls and to study the relationship between serum selenium concentration and severity of liver cirrhosis we conducted this casecontrol study on 100 subjects.
Study population:
Our study included 80 adult patients attending the out patients clinic and /or admitted to the inpatient section of the Department of Tropical Medicine and Gastroenterology, Sohag University Hospital.
The patients were categorized to four groups:The first group included fifteen patients with chronic hepatitis C. Qualitative data were presented as number and percentage and compared using either Chi square test or fisher exact test. Multivariate linear regression was done to determine the factors affecting selenium concentration and absorbance. Graphs were produced by using Excel or STATA program. P value was considered significant if it was less than 0.05.
Results
The mean age of our studied patients was 41.16 ±12.87 years, 68.8% of them were males. Our results showed that mean serum Selenium concentration was significantly lower in the studied cases compared to control group as showed in table (1).
Mean serum Selenium concentration was significantly lower in patients compared to healthy controls (43.34 ± 11.41 versus 84.45 ± 11.85, P value = <0.0001). It was also significantly lower in each of the studied groups (chronic hepatitis C, chronic hepatitis B, liver cirrhosis and HCC) when compared with healthy controls (P value < 0.0001; < 0.0001; < 0.0001; < 0.00001 respectively). However no significant difference was found in mean serum selenium between patients with chronic hepatitis B, chronic hepatitis C, and liver cirrhosis. Patients with HCC had significantly lower selenium level when compared to other groups (table 2) .
There was significant lower selenium concentration in patients with jaundice, ascites, bleeding tendency and hepatic encephalopathy in comparison to control group (P value 0.0001, 0.0008, 0.0001 and 0.0001 respectively). Patients with advanced liver cirrhosis (Child B, C) had significantly lower selenium level compared to those with Child A (P value <0.0001) figure (1 
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The results showed significant negative correlations between serum selenium level and each of total bilirubin, prothrombin time, AFP and liver enzymes. On the other hand, there were significant positive correlations between serum selenium level and each of serum albumin, prothrombin concentration, hemoglobin level and platelet count.
Multivariate regression analysis for the all significant variables in univariate analysis showed that the presence of chronic HBV, chronic HCV, liver cirrhosis and or HCC found to be independent risk factors for low serum selenium level table (3,4) .
Discussion
Selenium is essential trace element integrates into selenoproteins that have antioxidant and anti-inflammatory effects. Higher selenium status or selenium supplementation has also shown to have antiviral effects (Rayman, 2012). Moreover, selenium is an active immunomodulator, much more potent antioxidant than vitamins A, C, E and betacarotene (Ozardali et al., 2004 ).In the 1960s and 1970s epidemiological data began to demonstrate that selenium also possesses anti-carcinogenic activity (Murray, 1996).
We conducted this research in order to study serum selenium level in patients with chronic liver diseases compared to healthy controls and to study the relationship between serum selenium concentration and severity of liver cirrhosis.We found no significant differences as regard gender and age factors in the studied groups, as had previously been observed in healthy subject (Navarro et al., 1995) .
According to our results there was a significant decrease observed in serum selenium in patients with chronic hepatitis (chronic HBV and chronic HCV) in comparison to healthy controls. Different studies have shown same results in chronic hepatitis B and C patients. They found that the deficiency of selenium is common in patients with hepatitis and this was explained by the poor appetite during infection, decrease in intake and absorption, decreased bioavailability, and increased losses because of malabsorption (Zhang et al., 1999 Our result showed that serum Selenium was significantly decreased with signs of hepatic decompensation namely (jaundice, ascites, hepatic coma, and bleeding tendency) than without. Accordingly we found that patients with advanced liver disease (Child score B-C) had significantly lower serum Selenium concentrations than patients with compensated liver disease (Child score A). Similar results were found by previous studies, they postulated that serum selenium levels decreased as the disease advanced, reached the lowest level in the final stages (Dworkin et al., 1985 and Conri et al., 1988). These findings effectively confirm that the severity of the liver injury is one of the factors conditioning the impairment in the Selenium body status observed in patients with chronic liver disease.
Considering multivariate regression analysis for the all significant variables in univariate analysis showed that the presence of chronic HBV, chronic HCV, liver cirrhosis and / or HCC are independent risk factors for low serum selenium level. These findings agree with ., 2010) .Therefore, we believe that the possible prophylactic use of this element against increase in the severity of chronic liver disease should not be discarded and, therefore, should be subject of future research.
In conclusion serum selenium levels were significantly lower in patients with chronic liver disease than in healthy control group. Also, Serum Selenium levels significantly decreased in relation to the progression of chronic liver disease. Patients with HCC had the lowest serum Selenium concentration that might correlate with the pathophysiology of HCC. Chronic hepatitis C and B, liver cirrhosis and HCC were independent predictors of selenium deficiency.
